Laura Visa
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Lateral flow immunoassay detection of soluble AXL for pancreatic ductal adenocarcinoma diagnosis.
Journal: Talanta
Published: April 10, 2026
Next generation sequencing of circulating tumor DNA for precision medicine in patients with advanced biliary tract cancers.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 15, 2026
Real-world characterization of PD-L1 expression in patients with advanced esophagogastric adenocarcinoma in Spain.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: December 19, 2025
Claudin 18.2 expression in gastroesophageal adenocarcinoma: biomarker overlap and association with clinical outcomes in a European cohort.
Journal: ESMO open
Published: October 31, 2025
Does perioperative FLOT increase cure rates in resectable esophageal adenocarcinoma? A mixture cure model analysis.
Journal: British journal of cancer
Published: June 25, 2025
Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON-SEOM registry.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: December 22, 2023
Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: December 19, 2023
Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: May 26, 2023
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy.
Journal: Therapeutic advances in medical oncology
Published: August 17, 2022
Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry.
Journal: Journal of cancer research and clinical oncology
Published: June 16, 2022
Last Updated: 09/26/2026